FDA lowers starting dose for sleep medication Lunesta

Alex CukanWASHINGTON, May 15 (UPI) -- The U.S. Food and Drug Administration said Thursday the manufacturer of Lunesta, or eszopiclone, must change the label to recommend a lower starting dose.

Source: Health News - UPI.com - May 15, 2014 Category: Consumer Health News Source Type: news